İncir (Ficus Carica)
Synopsis
Kanser, yaygın bir küresel sağlık sorunu olup, geleneksel tedavilerin toksisite ve direnç gibi temel zorluklar nedeniyle yenilikçi tedavi yaklaşımlarına ihtiyaç duymaktadır. Taze ürün tüketiminin azalması ile kanser riski arasında dikkate değer bir ilişki bulunmaktadır. Bu bağlamda, Ficus carica, kanser tedavisi ile ilişkilendirilen karmaşıklıklara çözüm getirme potansiyeliyle ön plana çıkmaktadır.
Özellikle, F. carica'nın meyve lateksi, çeşitli kanser hücre hatları üzerinde proliferasyonu engelleme ve apoptozu tetikleme kapasitesini göstererek in vitro ortamda güçlü anti-kanser etkiler sergilemektedir. Kapsamlı araştırmalar, F. carica'nın NF-κB/IL-6/STAT3, PI3K/Akt/mTOR ve Bcl-2 gibi önemli sinyal yollarını etkileyerek çeşitli kanser türlerine karşı etkinliğini açığa çıkarmaktadır.
Ancak, F. carica'nın terapötik potansiyelini tam anlamıyla kullanabilmek için karmaşık mekanizmalarının daha derinlemesine anlaşılması zorunludur. Ayrıca, umut verici in vitro sonuçlarının klinik uygulamalara çevrilmesi için daha fazla kapsamlı klinik denemelere ihtiyaç vardır. Belirli bitki parçalarından elde edilen izole bileşenler ve yenilikçi formülasyonların kapsamlı bir şekilde araştırılması, F. carica'nın anti-kanser özelliklerinin anlaşılmasını artırmakla kalmayacak, aynı zamanda kanser tedavisinde etkili bir şekilde kullanılabilmesinin yolunu açacaktır.
Cancer, a pervasive global health concern, necessitates innovative treatment approaches due to the inherent challenges of traditional therapies, marked by issues like toxicity and resistance. A notable correlation exists between reduced consumption of fresh produce and an augmented risk of cancer. In this context, Ficus carica emerges as a promising candidate for therapeutic interventions, showcasing its potential to address the complexities associated with cancer treatment.
Specifically, F. carica's fruit latex exhibits robust anti-cancer effects in vitro, demonstrating its capacity to impede proliferation and induce apoptosis across various cancer cell lines. Comprehensive research illuminates the efficacy of F. carica against a spectrum of cancers, influencing pivotal signaling pathways such as NF-κB/IL-6/STAT3, PI3K/Akt/mTOR, and Bcl-2.
However, to fully harness the therapeutic potential of F. carica, a more profound comprehension of its intricate mechanisms is imperative. Additionally, the translation of promising in vitro results to clinical applications necessitates further rigorous clinical trials. A comprehensive exploration into isolated compounds and innovative formulations derived from specific plant parts will not only enhance our understanding of F. carica's anti-cancer properties but also pave the way for its effective utilization in cancer therapy.
References
Coates A, Abraham S, Kaye SB, Sowerbutts T, Frewin C, Fox R, et al. On the receiving end—patient perception of the side-effects of cancer chemotherapy. European Journal of Cancer and Clinical Oncology. 1983;19(2):203-8.
Huang X, Zhang Q, Kang X, Song Y, Zhao W. Factors associated with cancer-related fatigue in breast cancer patients undergoing endocrine therapy in an urban setting: a cross-sectional study. BMC cancer. 2010;10(1):1-7.
Ferguson PJ, Kurowska E, Freeman DJ, Chambers AF, Koropatnick DJ. A flavonoid fraction from cranberry extract inhibits proliferation of human tumor cell lines. The Journal of nutrition. 2004;134(6):1529-35.
Chawla A, Kaur R, Sharma AK. Ficus carica Linn.: A review on its pharmacognostic, phytochemical and pharmacological aspects. International Journal of Pharmaceutical and Phytopharmacological Research. 2012;1(4):215-32.
Herre EA, Jandér KC, Machado CA. Evolutionary ecology of figs and their associates: recent progress and outstanding puzzles. Annual Review of Ecology, Evolution, and Systematics. 2008;39:439-58.
Khare CP. Indian medicinal plants: an illustrated dictionary: Springer Science & Business Media; 2008.
Idolo M, Motti R, Mazzoleni S. Ethnobotanical and phytomedicinal knowledge in a long-history protected area, the Abruzzo, Lazio and Molise National Park (Italian Apennines). Journal of Ethnopharmacology. 2010;127(2):379-95.
Solomon A, Golubowicz S, Yablowicz Z, Grossman S, Bergman M, Gottlieb HE, et al. Antioxidant activities and anthocyanin content of fresh fruits of common fig (Ficus carica L.). Journal of agricultural and food chemistry. 2006;54(20):7717-23.
Wang J, Wang X, Jiang S, Lin P, Zhang J, Lu Y, et al. Cytotoxicity of fig fruit latex against human cancer cells. Food and chemical toxicology. 2008;46(3):1025-33.
Tezcan G, Tunca B, Bekar A, Yalcin M, Sahin S, Budak F, et al. Ficus carica latex prevents invasion through induction of let-7d expression in GBM cell lines. Cellular and molecular neurobiology. 2015;35:175-87.
Amessis-Ouchemoukh N, Ouchemoukh S, Meziant N, Idiri Y, Hernanz D, Stinco CM, et al. Bioactive metabolites involved in the antioxidant, anticancer and anticalpain activities of Ficus carica L., Ceratonia siliqua L. and Quercus ilex L. extracts. Industrial Crops and Products. 2017;95:6-17.
Jacob SJP, Prasad VS, Sivasankar S, Muralidharan P. Biosynthesis of silver nanoparticles using dried fruit extract of Ficus carica-Screening for its anticancer activity and toxicity in animal models. Food and Chemical Toxicology. 2017;109:951-6.
Abdel-Rahman R, Ghoneimy E, Abdel-Wahab A, Eldeeb N, Salem M, Salama E, et al. The therapeutic effects of Ficus carica extract as antioxidant and anticancer agent. South African Journal of Botany. 2021;141:273-7.
AlGhalban FM, Khan AA, Khattak MNK. Comparative anticancer activities of Ficus carica and Ficus salicifolia latex in MDA-MB-231 cells. Saudi Journal of Biological Sciences. 2021;28(6):3225-34.
Ergül M, Ergül M, Eruygur N, Mehmet A, Esra U. In vitro evaluation of the chemical composition and various biological activities of Ficus carica leaf extracts. Turkish Journal of Pharmaceutical Sciences. 2019;16(4):401.
Ghandehari F, Fatemi M. The effect of Ficus carica latex on 7, 12-dimethylbenz (a) anthracene-induced breast cancer in rats. Avicenna journal of phytomedicine. 2018;8(4):286.
Ghanbari A, Le Gresley A, Naughton D, Kuhnert N, Sirbu D, Ashrafi GH. Biological activities of Ficus carica latex for potential therapeutics in Human Papillomavirus (HPV) related cervical cancers. Scientific reports. 2019;9(1):1013.
Boyacıoğlu O, Kara B, Tecimen S, Kılıç M, Delibaş M, Erdoğan R, et al. Antiproliferative effect of Ficus carica latex on cancer cell lines is not solely linked to peroxidase-like activity of ficin. European Journal of Integrative Medicine. 2021;45:101348.
Abdel-Aty AM, Hamed MB, Salama WH, Ali MM, Fahmy AS, Mohamed SA. Ficus carica, Ficus sycomorus and Euphorbia tirucalli latex extracts: Phytochemical screening, antioxidant and cytotoxic properties. Biocatalysis and Agricultural Biotechnology. 2019;20:101199.
Liu Y-P, Guo J-M, Yan G, Zhang M-M, Zhang W-H, Qiang L, et al. Anti-inflammatory and antiproliferative prenylated isoflavone derivatives from the fruits of Ficus carica. Journal of agricultural and food chemistry. 2019;67(17):4817-23.
Sharma SH, Kumar JS, Chellappan DR, Nagarajan S. Molecular chemoprevention by morin–A plant flavonoid that targets nuclear factor kappa B in experimental colon cancer. Biomedicine & Pharmacotherapy. 2018;100:367-73.
Hashemi SA, Abediankenari S. Suppressive effect of fig (Ficus carica) latex on esophageal cancer cell proliferation. Acta Facultatis Medicae Naissensis. 2013;30(2):93.
Lu X, Wo G, Li B, Xu C, Wu J, Jiang C, et al. The anti-inflammatory NHE-06 restores antitumor immunity by targeting NF-κB/IL-6/STAT3 signaling in hepatocellular carcinoma. Biomedicine & Pharmacotherapy. 2018;102:420-7.
Jing L, Zhang Y-M, Luo J-G, Kong L-Y. Tirucallane-type triterpenoids from the fruit of Ficus carica and their cytotoxic activity. Chemical and Pharmaceutical Bulletin. 2015;63(3):237-43.
Menichini G, Alfano C, Provenzano E, Marrelli M, A Statti G, Somma F, et al. Fig latex (Ficus carica L. cultivar Dottato) in combination with UV irradiation decreases the viability of A375 melanoma cells in vitro. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents). 2012;12(8):959-65.
Marrelli M, Menichini F, Statti GA, Bonesi M, Duez P, Menichini F, et al. Changes in the phenolic and lipophilic composition, in the enzyme inhibition and antiproliferative activity of Ficus carica L. cultivar Dottato fruits during maturation. Food and Chemical Toxicology. 2012;50(3-4):726-33.
Conforti F, Menichini G, Zanfini L, Tundis R, Statti G, Provenzano E, et al. Evaluation of phototoxic potential of aerial components of the fig tree against human melanoma. Cell Proliferation. 2012;45(3):279-85.
Hashemi S, Abediankenari S, Ghasemi M, Azadbakht M, Yousefzadeh Y, Dehpour A. The effect of fig tree latex (Ficus carica) on stomach cancer line. Iranian Red Crescent Medical Journal. 2011;13(4):272.
Fahmy MA, Hassan EE, Ibrahim NE, Hassan EM, Hassan ZM, Omara EA. Protective role of Ficus carica extract against hepato-testicular side effects and genotoxicity induced by cisplatin. Pharmacognosy Journal. 2020;12(3).
Aziz B, Khurshid A, Mahmood R, Khan JA, Javaid S, Alam M, et al. Study of synergistic effects of Ficus Carica leaves extract mediated chemo-photodynamic therapy on rhabdomyosarcoma cells. Photodiagnosis and Photodynamic Therapy. 2021;36:102565.
Elghareeb MM, Elshopakey GE, Hendam BM, Rezk S, Lashen S. Synergistic effects of Ficus Carica extract and extra virgin olive oil against oxidative injury, cytokine liberation, and inflammation mediated by 5-Fluorouracil in cardiac and renal tissues of male albino rats. Environmental Science and Pollution Research. 2021;28:4558-72.
